tiprankstipranks
Trending News
More News >

Cogent Biosciences price target lowered to $8 from $10 at Baird

Baird lowered the firm’s price target on Cogent Biosciences (COGT) to $8 from $10 and keeps a Neutral rating on the shares. The firm updated its model following its Q4 results and sees three registrational readouts on track for 2025.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue